HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beta-Carotene Environmental Factors May Influence Study Results

This article was originally published in The Tan Sheet

Executive Summary

Future studies of chemopreventive agents such as beta-carotene should take into account the variations between the nutrient's natural and synthetic forms as well as environmental factors, several researchers state in the June 21 issue of the Journal of the National Cancer Institute.

You may also be interested in...



Beta Carotene Pre-Gastric Cancer Lesion Prevention Shown In Study

Supplementation with beta carotene may inhibit the progression of lesions leading to stomach cancer - a finding contrary to previous studies that reported the carotenoid to be ineffective at preventing cancer.

Vitamins C, E, Selenium Upper Limits Set For First Time By FNB

The Institute of Medicine's Food & Nutrition Board announced selenium upper intake limits for the first time, setting the maximum safe intake amount at 400 mcg/day. The last review of safe and effective intake levels for antioxidants by the National Academy of Sciences group was in 1989.

Beta carotene

Women randomly assigned to receive 50 mg of the antioxidant on alternate days showed "no statistically significant differences in incidence of cancer, cardiovascular disease or total mortality after a median of 4.1 years," Women's Health Study researchers report in the December Journal of the National Cancer Institute. Over a median treatment duration of 2.1 years, 19,939 women received beta carotene and an equal number were given placebo; follow-up lasted for two years. The study recorded 378 cancers in the beta carotene group compared to 369 among controls, 42 instances of MI compared to 50 for controls and 61 cases of stroke compared to 43 for controls. The results mirror those from other studies, including the Carotene & Retinol Efficacy Trial and the Alpha-Tocopherol, Beta Carotene Cancer Prevention study

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel